BioNitrogen Receives Final Engineering Feasibility Studies From the Casale Group
January 13 2014 - 9:23AM
Marketwired
BioNitrogen Receives Final Engineering Feasibility Studies From the
Casale Group
WEST PALM BEACH, FL--(Marketwired - Jan 13, 2014) - BioNitrogen
Holdings Corp. (PINKSHEETS: BION), a cleantech company that
utilizes patented technology to build environmentally-friendly
plants that convert biomass into urea fertilizer, announced today
that the Casale Group has finished the engineering feasibility
studies for its portion of BioNitrogen's plants.
The feasibility reports are detailed basic engineering packages
that describe elements of the ammonia and urea plants such as
design capacities, production outputs, process flow diagrams and
equipment lists. It is the prerequisite information required to
properly estimate the cost of the plants. This information will be
integrated into the rest of the plant design by the CCC Group and
AMEC as the design of the overall plant nears completion.
"Casale's reports demonstrate tremendous 'behind-the-scenes'
progress over the last few months that significantly advance the
project forward. The next steps for Casale are to begin the initial
cost estimates for the ammonia and urea equipment necessary for EPC
funding," said Ernie Iznaga, VP of Operations at BioNitrogen.
Recently, the company announced that it has funded BioResource
Management, Inc. to conduct feasibility studies for biomass
feedstock supply agreements to the BioNitrogen plants in the states
of Florida and Louisiana.
About BioNitrogen Holdings Corp. BioNitrogen Holdings Corp.
(PINKSHEETS: BION) is a cleantech company that utilizes patented
technology to build environmentally-friendly plants that convert
biomass into urea fertilizer. Our mission is to provide safe, cost
effective, green solutions that are economically beneficial in
locations where biomass is produced and urea is consumed.
Additional information can be found at www.BioNitrogen.com
Safe Harbor Statement The forward-looking statements contained
in this document involve risks and uncertainties that may affect
the Company's operations, markets, products, services, prices and
other factors as discussed in filings with the Securities and
Exchange Commission. These risks and uncertainties include, but are
not limited to, economic, competitive, legal, governmental and
technological factors. Accordingly, there is no assurance that the
Company's expectations will be realized. The Company assumes no
obligation to provide revisions to any forward-looking statements
should circumstances change, except as otherwise required by
securities and other applicable laws.
Contact Adam Friedman Principal Email Contact 917-675-6250
BioNitrogen (CE) (USOTC:BIONQ)
Historical Stock Chart
From Mar 2024 to Apr 2024
BioNitrogen (CE) (USOTC:BIONQ)
Historical Stock Chart
From Apr 2023 to Apr 2024